SKI Market

A+| A| A-|

Indian Indices

Sensex

74,243.34 -116.67
( -0.16%)

Global Indices

Nasdaq

51,098.17 -484.76
(-0.94%)

Dow Jones

7,440.28 -165.03
(-2.17%)

Hang Seng

66,711.59 -759.10
(-1.13%)

Nikkei 225

10,374.30 13.98
(0.13%)

Forex

USD-INR

95.73 0.01
(0.01%)

EUR-INR

111.21 0.07
(0.06%)

GBP-INR

128.58 -0.06
(-0.05%)

JPY-INR

0.60 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

338.0498657

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

39.29

37200.83

EPS(TTM)

Face Value()

Div & Yield %

75.78

Back

Systematix Corporate Services consolidated net profit declines 96.29% in the December 2025 quarter

Jan 27,2026

Net profit of Systematix Corporate Services declined 96.29% to Rs 0.69 crore in the quarter ended December 2025 as against Rs 18.58 crore during the previous quarter ended December 2024. Sales declined 20.51% to Rs 33.60 crore in the quarter ended December 2025 as against Rs 42.27 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	33.60	42.27	-21
OPM %	11.43	51.05	-
PBDT	2.98	24.97	-88
PBT	1.78	24.18	-93
NP	0.69	18.58	-96

74,243.34 -116.67 ( -0.16%)

51,098.17 -484.76 (-0.94%)

7,440.28 -165.03 (-2.17%)

66,711.59 -759.10 (-1.13%)

10,374.30 13.98 (0.13%)

95.73 0.01 (0.01%)

111.21 0.07 (0.06%)

128.58 -0.06 (-0.05%)

0.60 0.00 (0.01%)